首页> 外文OA文献 >018 The breast cancer, early disease: toxicity from therapy with epirubicin regimens ¨ c cardiac assessment and risk evaluation (better-care), cardiovascular magnetic resonance (CMR) sub-study: cycle 1 changes predict late anthracycline cardiotoxicity: Abstract 018 Table 1

【2h】

018 The breast cancer, early disease: toxicity from therapy with epirubicin regimens ¨ c cardiac assessment and risk evaluation (better-care), cardiovascular magnetic resonance (CMR) sub-study: cycle 1 changes predict late anthracycline cardiotoxicity: Abstract 018 Table 1

机译：018乳腺癌，早期疾病：从联合霉素治疗毒性方案¨c心脏评估和风险评估（更好的保健），心血管磁共振（CMR）次研究：循环1变化预测晚期蒽环毒素心脏毒性：摘要018表1

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
G C Smith; P Kotwinski; J Sanders; J Cooper; L Ma; A Jones; M G Mythen; H E Montgomery; D J Pennell;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chroni [J] . Paul Kotwinski, Gillian Smith, Julie Sanders, Journal of cardiovascular magnetic resonance : . 2013,第Suppla1期

机译：乳腺癌，早期疾病：表柔比星疗法治疗的毒性-心脏评估和风险评估（BETTER-CARE）研究：早期g相对增强而不是高敏感性肌钙蛋白T的CMR可以预测发生慢性的风险
2. The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chroni [J] . Paul Kotwinski, Gillian Smith, Julie Sanders, Journal of cardiovascular magnetic resonance : . 2013,第Suppla1期

机译：乳腺癌，早期疾病：表柔比星疗法治疗的毒性-心脏评估和风险评估（BETTER-CARE）研究：早期g相对增强而不是高敏感性肌钙蛋白T的CMR可以预测发生慢性的风险
3. Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: The LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue doppler imaging Evaluation) randomized pilot study [J] . LotrionteM., PalazzoniG., AbbateA., International Journal of Cardiology . 2013,第3期

机译：基于非聚乙二醇脂质体的阿霉素方案与基于表柔比星的方案对乳腺癌的心脏毒性：LITE（脂质体阿霉素-研究性化学疗法-组织多普勒成像评估）随机先导研究
4. The breast cancer early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement but not high-sensitivity troponin T predicts the risk of chronic anthracycline cardiotoxicity [O] . Paul Kotwinski, Gillian Smith, Julie Sanders, 2013

机译：乳腺癌早期疾病：表柔比星疗法治疗的毒性-心脏评估和风险评估（BETTER-CARE）研究：早期relative相对增强而不是高敏感性肌钙蛋白T的CMR预测了慢性蒽环类药物具有心脏毒性的风险
5. The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity [O] . Paul Kotwinski, Gillian Smith, Julie Sanders, 2017

机译：乳腺癌，早期疾病：表柔比星疗法治疗的毒性-心脏评估和风险评估（BETTER-CARE）研究：早期relative相对增强而不是高敏感性肌钙蛋白T的CMR预测了慢性蒽环类药物具有心脏毒性的风险

018 The breast cancer, early disease: toxicity from therapy with epirubicin regimens ¨ c cardiac assessment and risk evaluation (better-care), cardiovascular magnetic resonance (CMR) sub-study: cycle 1 changes predict late anthracycline cardiotoxicity: Abstract 018 Table 1

著录项

相似文献

相关主题

期刊订阅